KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

Tuesday's IBD 50 Stocks To Watch pick is biotech stock Travere Therapeutics, which is pulling back to a key support level. That makes the kidney disease leader one of the best ideas to watch right now ...

Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.

People with chronic kidney disease and type 2 diabetes may face heart disease up to 28 years earlier than others.

Scientists from Ghana, Nigeria, and the United States have published groundbreaking research in the New England Journal of ...

Nearly 300,000 bottles of the drug, named Cinacalcet, were recalled and given a Class II recall risk level by the FDA.

A new study reveals that people with both type 2 diabetes and chronic kidney disease are at a much higher risk of developing ...

We first introduced you to Brandon Talley four years ago. The father of three was in dire need of a kidney. He was diagnosed ...

Calcium levels decreased less with each subsequent denosumab dose among individuals with osteoporosis and advanced chronic kidney disease.

It's not only about how the diabetes is managed but also about the long-term complications that may follow. Poorly controlled ...